Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for ilaris
Yes. Ilaris is a biologic medicine. It contains rilonacept, a biologic drug made from a protein-based construct designed to interfere with inflammation by acting as a decoy receptor for specific inflammatory signals.
Ilaris is not a monoclonal antibody. It is a receptor fusion protein (a decoy receptor) biologic rather than an antibody that binds a single target in the way monoclonal antibodies typically do.
Because Ilaris is biologic, it’s generally supplied and used as a specialized protein therapy (not a small-molecule pill). Biologics also tend to be regulated and manufactured under biologics-specific pathways, which matters for topics like biosimilar availability and substitution rules.
Other Questions About Ilaris :